188 related articles for article (PubMed ID: 10516882)
1. Rhabdomyolysis induced by simvastatin and ketoconazole treatment.
Gilad R; Lampl Y
Clin Neuropharmacol; 1999; 22(5):295-7. PubMed ID: 10516882
[TBL] [Abstract][Full Text] [Related]
2. Clinical reasoning: rhabdomyolysis after combined treatment with simvastatin and fluconazole.
Findling O; Meier N; Sellner J; Nedeltchev K; Arnold M
Neurology; 2008 Oct; 71(15):e34-7. PubMed ID: 18838657
[No Abstract] [Full Text] [Related]
3. A lesson for everyone in drug-drug interactions.
Akram K; Rao S; Parker M
Int J Cardiol; 2007 May; 118(1):e19-20. PubMed ID: 17368833
[TBL] [Abstract][Full Text] [Related]
4. Successful re-challenge of daptomycin therapy after initial rhabdomyolysis with co-administration of simvastatin.
Bland CM; Bookstaver PB; Thomas S
Int J Antimicrob Agents; 2011 Dec; 38(6):549-50. PubMed ID: 21958456
[No Abstract] [Full Text] [Related]
5. Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.
Lasocki A; Vote B; Fassett R; Zamir E
Ocul Immunol Inflamm; 2007; 15(4):345-6. PubMed ID: 17763133
[TBL] [Abstract][Full Text] [Related]
6. Drug-interaction-induced rhabdomyolysis.
Segaert MF; De Soete C; Vandewiele I; Verbanck J
Nephrol Dial Transplant; 1996 Sep; 11(9):1846-7. PubMed ID: 8918636
[No Abstract] [Full Text] [Related]
7. How common is rhabdomyolysis in patients receiving lipid-lowering therapy?
Phillips PS
Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):130-1. PubMed ID: 16265453
[No Abstract] [Full Text] [Related]
8. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
Masana L; Mata P; Gagné C; Sirah W; Cho M; Johnson-Levonas AO; Meehan A; Troxell JK; Gumbiner B;
Clin Ther; 2005 Feb; 27(2):174-84. PubMed ID: 15811480
[TBL] [Abstract][Full Text] [Related]
9. [Drug interaction caused by communication problems. Rhabdomyolysis due to a combination of itraconazole and simvastatin].
Tiessen RG; Lagerwey HJ; Jager GJ; Sprenger HG
Ned Tijdschr Geneeskd; 2010; 154():A762. PubMed ID: 20456775
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.
Molden E; Andersson KS
Pharmacotherapy; 2007 Apr; 27(4):603-7. PubMed ID: 17381388
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyolysis in a Prostate Cancer Patient Taking Ketoconazole and Simvastatin: Case Report and Review of the Literature.
Watkins JL; Atkinson BJ; Pagliaro LC
Ann Pharmacother; 2011 Feb; 45(2):e9. PubMed ID: 21304039
[TBL] [Abstract][Full Text] [Related]
12. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
[TBL] [Abstract][Full Text] [Related]
13. Statin-associated rhabdomyolysis triggered by drug-drug interaction with itraconazole.
Dybro AM; Damkier P; Rasmussen TB; Hellfritzsch M
BMJ Case Rep; 2016 Sep; 2016():. PubMed ID: 27605198
[TBL] [Abstract][Full Text] [Related]
14. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
15. Fatal rhabdomyolysis caused by lipid-lowering therapy.
Federman DG; Hussain F; Walters AB
South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
[TBL] [Abstract][Full Text] [Related]
16. Rhabdomyolysis-induced acute renal failure due to itraconazole and simvastatin association.
Roques S; Lytrivi M; Rusu D; Devriendt J; De Bels D
Drug Metabol Drug Interact; 2011; 26(2):79-80. PubMed ID: 21495875
[TBL] [Abstract][Full Text] [Related]
17. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil-simvastatin interaction: possible cause of rhabdomyolysis?
Gutierrez CA
Am Fam Physician; 2001 Feb; 63(4):636-7. PubMed ID: 11237079
[No Abstract] [Full Text] [Related]
20. Risk for fatal statin-induced rhabdomyolysis as a consequence of misinterpretation of 'evidence-based medicine'.
Eriksson M; Angelin B; Sjöberg S
J Intern Med; 2005 Mar; 257(3):313-4. PubMed ID: 15715689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
